menu
    • menu

    Company profile for Belite Bio

    NEW Drugs in Dev: 1
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Belite Bio™ is a San Diego-based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease and diabetes. Developed from our RBP4 platform technology, our lead candidate, LBS-008, is currently in a Phase I clinical trial for dry age-related macular degeneration and its juvenile form, Stargardt disease. LBS-008 has received O...
    Belite Bio™ is a San Diego-based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease and diabetes. Developed from our RBP4 platform technology, our lead candidate, LBS-008, is currently in a Phase I clinical trial for dry age-related macular degeneration and its juvenile form, Stargardt disease. LBS-008 has received Orphan Drug Designation in the US and Europe, as well as Rare Pediatric Disease Designation in the US.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Belite BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    210 Merryfield Row San Diego CA, 92121
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://belitebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/belitebio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Belite Bio to Host 2025 Financials Webcast March 2, 2026
    Belite Bio to Host 2025 Financials Webcast March 2, 2026

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242579/0/en/Belite-Bio-to-Host-Webcast-on-March-2-2026-to-Discuss-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Belite Bio Announces Participation at 41st APAO Congress
    Belite Bio Announces Participation at 41st APAO Congress

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3228538/0/en/Belite-Bio-Announces-Participation-at-the-41st-Asia-Pacific-Academy-of-Ophthalmology-Congress-APAO.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    Belite Bio Finishes Enrolling Patients In Tinlarebant Trial
    Belite Bio Finishes Enrolling Patients In Tinlarebant Trial

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226453/0/en/Belite-Bio-Completes-Enrollment-in-the-DRAGON-II-Clinical-Trial-of-Tinlarebant-for-Stargardt-Disease-STGD1.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Belite Brings FDA Filing Into View with Phase 3 Stargardt Win
    Belite Brings FDA Filing Into View with Phase 3 Stargardt Win

    01 Dec 2025

    // PRESS RELEASE

    https://investors.belitebio.com/news-releases/news-release-details/new-hope-people-living-disease-once-deemed-untreatable-belite

    PRESS RELEASE
    01 Dec 2025
    Share Share
    Belite Announces Proposed Underwritten Public Offering of Shares
    Belite Announces Proposed Underwritten Public Offering of Shares

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197471/0/en/Belite-Bio-Announces-Proposed-Underwritten-Public-Offering-of-American-Depositary-Shares.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Belite Bio Reports Q3 2025 Financial Results & Corporate Update
    Belite Bio Reports Q3 2025 Financial Results & Corporate Update

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184490/0/en/Belite-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Provides-a-Corporate-Update.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search